{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:24:14Z","timestamp":1777055054271,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5447-1","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T07:02:56Z","timestamp":1553756576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Alexandre","family":"Harl\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Demange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Dolivet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Peiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-0603","authenticated-orcid":false,"given":"Xavier","family":"Sastre-Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"issue":"4","key":"5447_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.24075","volume":"124","author":"P Cremoux de","year":"2009","unstructured":"de Cremoux P, de la Rochefordiere A, Savignoni A, Kirova Y, Alran S, Fourchotte V, et al. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer. 2009;124(4):778\u201382.","journal-title":"Int J Cancer"},{"issue":"1","key":"5447_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.28963","volume":"136","author":"L Alemany","year":"2014","unstructured":"Alemany L, Saunier M, Alvarado-Cabrero I, Quiros B, Salmeron J, Shin HR, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2014;136(1):98\u2013107.","journal-title":"Int J Cancer"},{"issue":"16","key":"5447_CR3","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","volume":"49","author":"S Sanjose de","year":"2013","unstructured":"de Sanjose S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450\u201361.","journal-title":"Eur J Cancer"},{"issue":"9","key":"5447_CR4","first-page":"2359","volume":"19","author":"L Peder de","year":"2018","unstructured":"de Peder L, da Silva C, Lenartovickz Boeira V, Plewka J, Turkiewicz M, Lopes Consolaro M, et al. Association between human papillomavirus and non-cervical genital cancers in Brazil: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2018;19(9):2359\u201371.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"5447_CR5","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/1471-2407-14-968","volume":"14","author":"S Abogunrin","year":"2014","unstructured":"Abogunrin S, Di Tanna GL, Keeping S, Carroll S, Iheanacho I. Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis. BMC Cancer. 2014;14(1):968.","journal-title":"BMC Cancer"},{"issue":"3","key":"5447_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/00006250-199203000-00002","volume":"79","author":"AT Lorincz","year":"1992","unstructured":"Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;79(3):328\u201337.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"5447_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/path.1490","volume":"202","author":"AH Hopman","year":"2004","unstructured":"Hopman AH, Smedts F, Dignef W, Ummelen M, Sonke G, Mravunac M, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16\/18 and numerical chromosome abnormalities. J Pathol. 2004;202(1):23\u201333.","journal-title":"J Pathol"},{"issue":"3","key":"5447_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/path.2713","volume":"221","author":"M Peter","year":"2010","unstructured":"Peter M, Stransky N, Couturier J, Hupe P, Barillot E, de Cremoux P, et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol. 2010;221(3):320\u201330.","journal-title":"J Pathol"},{"issue":"21","key":"5447_CR9","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","volume":"78","author":"K Munger","year":"2004","unstructured":"Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78(21):11451\u201360.","journal-title":"J Virol"},{"issue":"5","key":"5447_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"5447_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","volume":"48","author":"MA O'Rorke","year":"2012","unstructured":"O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012;48(12):1191\u2013201.","journal-title":"Oral Oncol"},{"key":"5447_CR12","doi-asserted-by":"crossref","unstructured":"Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, et al. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. J Clin Oncol. 2018;36(31):3152\u201361.","DOI":"10.1200\/JCO.18.00684"},{"issue":"6","key":"5447_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/bjc.2017.258","volume":"117","author":"JY Lee","year":"2017","unstructured":"Lee JY, Garcia-Murillas I, Cutts RJ, De Castro DG, Grove L, Hurley T, et al. Predicting response to radical (chemo) radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma. Br J Cancer. 2017;117(6):876\u201383.","journal-title":"Br J Cancer"},{"key":"5447_CR14","doi-asserted-by":"publisher","unstructured":"Han K, Leung E, Barbera L, Barnes E, Croke J, Di Grappa MA, et al. Circulating human papillomavirus DNA as a biomarker of response in patients with locally advanced cervical cancer treated with definitive chemoradiation. JCO Precis Oncol. 2018. \n                    https:\/\/doi.org\/10.1200\/PO.18.00152\n                    \n                  .","DOI":"10.1200\/PO.18.00152"},{"key":"5447_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/npjgenmed.2016.4","volume":"1","author":"A Holmes","year":"2016","unstructured":"Holmes A, Lameiras S, Jeannot E, Marie Y, Castera L, Sastre-Garau X, et al. Mechanistic signatures of HPV insertions in cervical carcinomas. Npj Genomic Med. 2016;1:16004.","journal-title":"Npj Genomic Med"},{"issue":"1","key":"5447_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/path.2532","volume":"218","author":"X Sastre-Garau","year":"2009","unstructured":"Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol. 2009;218(1):48\u201356.","journal-title":"J Pathol"},{"issue":"1","key":"5447_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L","volume":"92","author":"F Luft","year":"2001","unstructured":"Luft F, Klaes R, Nees M, Durst M, Heilmann V, Melsheimer P, et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer. 2001;92(1):9\u201317.","journal-title":"Int J Cancer"},{"key":"5447_CR18","first-page":"6132","volume":"59","author":"R Klaes","year":"1999","unstructured":"Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, et al. Detection of high risk cervical intra-\u00e9pithelial neoplasia and cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 1999;59:6132\u20136.","journal-title":"Cancer Res"},{"issue":"6","key":"5447_CR19","doi-asserted-by":"publisher","first-page":"e66693","DOI":"10.1371\/journal.pone.0066693","volume":"8","author":"B Xu","year":"2013","unstructured":"Xu B, Chotewutmontri S, Wolf S, Klos U, Schmitz M, Durst M, et al. Multiplex identification of human papillomavirus 16 DNA integration sites in cervical carcinomas. PLoS One. 2013;8(6):e66693.","journal-title":"PLoS One"},{"issue":"2","key":"5447_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ng.3178","volume":"47","author":"Z Hu","year":"2015","unstructured":"Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X, et al. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet. 2015;47(2):158\u201363.","journal-title":"Nat Genet"},{"issue":"5","key":"5447_CR21","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.18632\/oncotarget.12830","volume":"8","author":"M Tuna","year":"2017","unstructured":"Tuna M, Amos CI. Next generation sequencing and its applications in HPV-associated cancers. Oncotarget. 2017;8(5):8877\u201389.","journal-title":"Oncotarget"},{"issue":"8","key":"5447_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043393","volume":"7","author":"M Campitelli","year":"2012","unstructured":"Campitelli M, Jeannot E, Peter M, Lappartient E, Saada S, de la Rochefordiere A, et al. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One. 2012;7(8):e43393.","journal-title":"PLoS One"},{"issue":"8","key":"5447_CR23","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/ijc.30863","volume":"141","author":"L Cabel","year":"2017","unstructured":"Cabel L, Bidard FC, Servois V, Cacheux W, Mariani P, Romano E, et al. HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: a case report. Int J Cancer. 2017;141(8):1667\u201370.","journal-title":"Int J Cancer"},{"issue":"2","key":"5447_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/IGC.0000000000000049","volume":"24","author":"WS Liang","year":"2014","unstructured":"Liang WS, Aldrich J, Nasser S, Kurdoglu A, Phillips L, Reiman R, et al. Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing. Int J Gynecol Cancer. 2014;24(2):329\u201338.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"5447_CR25","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/ijc.30243","volume":"139","author":"C Bodelon","year":"2016","unstructured":"Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N. Genomic characterization of viral integration sites in HPV-related cancers. Int J Cancer. 2016;139(9):2001\u201311.","journal-title":"Int J Cancer"},{"key":"5447_CR26","doi-asserted-by":"crossref","unstructured":"Jeannot E, Harle A, Holmes A, Sastre-Garau X. Nuclear factor I X is a recurrent target for HPV16 insertions in anal carcinomas. Genes Chromosomes Cancer. 2018;57(12):638\u201344.","DOI":"10.1002\/gcc.22675"},{"key":"5447_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejogrb.2015.04.004","volume":"191","author":"E Padalko","year":"2015","unstructured":"Padalko E, Ali-Risasi C, Van Renterghem L, Bamelis M, De Mey A, Sturtewagen Y, et al. Evaluation of the clinical significance of human papillomavirus (HPV) 53. Eur J Obstet Gynecol Reprod Biol. 2015;191:7\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5447-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5447-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5447-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:12:55Z","timestamp":1585267975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5447-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5447"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5447-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the Internal Scientific Committee of the Institut de Canc\u00e9rologie de Lorraine and by the Comit\u00e9 de Protection des Personnes Est III (CPP 16\u201304-04). A signed consent to participate to the study was provided by the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"according to the French regulation, written informed consent was obtained to perform the research and publish the result of the study and accompanying images from the medical file. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"277"}}